More than 40% reduction in losses in the first half of the year, but multiple peers have achieved profits. BeiGene is facing increasing peer pressure
寒香小凡瓤
发表于 2024-8-31 11:37:35
1207
0
0
In the first half of the year, BeiGene (688235.SH, stock price 145.48 yuan, market value 2002.31 billion yuan) has been the "leader" in China's new drug industry for more than 2 years, but has not yet achieved profitability, despite reducing losses by over 40% but multiple peers have achieved profitability. BeiGene is facing increasing "peer pressure". On August 29th, BeiGene released its 2024 semi annual report, achieving a revenue of 11.996 billion yuan in the first half of the year, a year-on-year increase of 65.44%; The net profit attributable to the parent company was 2.877 billion yuan, with a year-on-year decrease of 44.87% in losses and a loss of 5.219 billion yuan in the same period last year.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Taobao announces the addition of multiple WeChat Pay companies involved in mobile payments
- Miniso's Mainland Same Store GMV Negative Growth in the First Half of the Year, Closing Rate Reaches a New High in Nearly Three Years, Bet on 'Going Global' Challenges
- AbbVie sues for infringement again, BeiGene denies allegations: this move is intended to prevent project development
- Omdia: iPhone 15 Pro Max became the world's best-selling smartphone with 21.8 million units shipped in the first half of the year
- Yunmi Electric sues multiple companies for infringement and seeks compensation of 8 million yuan
- Domestic innovative drug leader faces another 'patent challenge': AbbVie accuses BTK degradation agent of infringement, causing BeiGene's stock price to suffer a setback
- Powerful Fund Investment Advisor, JD Financial Partners, Top 100 Investment Advisors, and Multiple Institutions
- BeiGene denies AbbVie's accusation of "stealing trade secrets": will launch a firm defense and development projects will not be interrupted as a result
- BeiGene responds to AbbVie's lawsuit alleging theft of trade secrets: with the intention of obstructing the development process
- In the first half of 2024, Huize achieved a total revenue of 590 million yuan
-
9月が終わり、映画・テレビ業界が暗躍している。最近、愛奇芸の創始者でCEOのGONG宇氏は、映画・テレビ業界が長短の変化、AIの変化、中国映画・テレビドラマの海外進出の変化の3つの変化を経験していると発表した。 ...
- 寒郁轩良
- 1 小时前
- 支持
- 反对
- 回复
- 收藏
-
8月のトヨタ自動車(ダイハツ自動車と日野自動車を除く、レクサスを含む)の世界生産台数は前年同月比11.2%減の709571台、世界販売台数は前年同月比3.1%減の826863台だった。 日本本土市場では、トヨタ自動車の8月 ...
- SOGO
- 前天 18:03
- 支持
- 反对
- 回复
- 收藏
-
ネットワーク状況監視サイトDownDetectorによると、オーディオストリーミングプラットフォームSpotifyは日曜日に約3時間にわたる障害を経験した後、正常に回復し、ピーク時には米国の4万人以上のユーザーに影響を与 ...
- hecgdge4
- 6 小时前
- 支持
- 反对
- 回复
- 收藏
-
百済神州(688235.SH)はA株の有名な革新薬企業で、2017-2024年上半期、同社の各期の研究開発投資はA株の化学製薬会社(申万二級)の中で最も高く、研究開発費用は合計600億元を超えた。 しかし、百済神州にとって ...
- wylz8473
- 昨天 18:36
- 支持
- 反对
- 回复
- 收藏